Issue 20, 2020

Mitochondria-targeting monofunctional platinum(ii)–lonidamine conjugates for cancer cell de-energization

Abstract

Monofunctional Pt(II) complexes represent a class of antitumor agents that may expand the antitumor spectrum and overcome the drug resistance of the clinically used cisplatin and its derivatives. Herein, we designed three novel monofunctional Pt(II) complexes, namely, MPL-I, MPL-II and MPL-III, by anchoring lonidamine (an inhibitor of mitochondrial hexokinase) to the Pt(II) centre for the selective de-energization of cancer cells. Among them, MPL-III is more potent than cisplatin against triple negative breast cancer MDA-MB-231 cells and exhibits relatively lower cytotoxicity on breast epithelial cells. Intracellular distribution studies reveal that MPL-III mainly accumulates in the mitochondria. Furthermore, MPL-III induces detrimental changes in the mitochondrial ultrastructure and significant loss of the mitochondrial membrane potential, inhibits glycolysis and disrupts mitochondrial respiration. As a consequence, MPL-III causes cell cycle arrest in the G0/G1 phase, and mitochondria-mediated apoptosis involving caspase activation and cytochrome c release. RNA-sequencing data show that MPL-III perturbs the pathways including DNA damage, metabolic process and transcription regulator activity. Our research provides an in-depth study and a new design strategy for effective mono-functional platinum complexes with action mechanisms distinct from those of the clinical platinum-based anticancer drugs.

Graphical abstract: Mitochondria-targeting monofunctional platinum(ii)–lonidamine conjugates for cancer cell de-energization

Supplementary files

Article information

Article type
Research Article
Submitted
25 Aug 2020
Accepted
30 Aug 2020
First published
31 Aug 2020

Inorg. Chem. Front., 2020,7, 4010-4019

Mitochondria-targeting monofunctional platinum(II)–lonidamine conjugates for cancer cell de-energization

N. Muhammad, C. Tan, K. Muhammad, J. Wang, N. Sadia, Z. Pan, L. Ji and Z. Mao, Inorg. Chem. Front., 2020, 7, 4010 DOI: 10.1039/D0QI01028F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements